Chemotherapy plus G-CSF mobilized peripheral blood stem cell harvests from acute myeloid leukaemia patients contain large amounts of polyclonal myeloid linnegCD11cpos dendritic precursor cells

British Journal of Haematology

Volumn 124, Issue 5, 2004, Pages 636-644

  Sánchez, Joaquín ^a   Herrera, Concepción ^a   Torres, Antonio ^a   Román Gómez, José ^a   Álvarez, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Acute myeloid leukaemia; Dendritic cells; PBSC harvests

Indexed keywords

ANDROGEN RECEPTOR; B7 ANTIGEN; BUSULFAN; CARMUSTINE; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW CELL; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CELL FUNCTION; CELL LYSATE; CELL MATURATION; CELL MOTILITY; CELL STRUCTURE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MEGADOSE; FEMALE; GENE LOCUS; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSTIMULATION; LEUKAPHERESIS; LEUKEMIA CELL; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METHYLATION; PURIFICATION; STEM CELL; T LYMPHOCYTE;

ANTIGENS, CD11; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLONE CELLS; DENDRITIC CELLS; FEASIBILITY STUDIES; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MYELOID CELLS; PHENOTYPE;

EID: 1542299626     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04818.x     Document Type: Article

References (37)

1. Arpinati, M., Green, C.L., Heimfeld, S., Heuser, J.E. & Anasetti, C. (2000) Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood, 95, 2484-2490.
2. Avigan, D., Wu, Z., Gong, J., Joyce, R., Levine, J., Elias, A., Richardson, P., Milano, J., Kennedy, L., Anderson, K. & Kufe, D. (1999) Selective in vivo mobilization wit Granulocyte Macrophage colony-stimulating factor (GM-CSF)/Granocyte-SCF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation. Clinical Cancer Research, 5, 2735-2741.
3. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B. & Palucka, K. (2000) Immunobiology of dendritic cells. Annual Review of Immunology, 18, 767-811.
4. Bruserud, Ø., Tjønnfjord, G., Gjertsen, B.T., Foss, B. & Ernst, P. (2000) New strategies in the treatment of acute myelogenous leukaemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients. Stem cells, 18, 343-351.
5. Choudhury, A., Liang, J.C., Thomas, E.K., Flores-Romo, L., Xie, Q.S., Agusala, K., Sutaria, S., Sinha, I., Champlin, R.E. & Claxton, D.F. (1999) Dendritic cells derived in vitro from acute myelogeneous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood, 93, 780-786.
6. Claxton, D. & Choudhury, A. (2001) Potential for therapy with AML-derived dendritic cells. Leukemia, 15, 668-669.
7. Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D.W. & Schmitz, J. (2000) BDCA-2, BDCA-3 and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. Journal of Immunology, 165, 6037-6046.
8. Feller, N., Schuurhuis, G.J., van der Pol, M.A., Westra, G., Weijers, G.W.D, van Stijn, A., Huijgens, P.C. & Ossenkoppele, G.J. (2003) High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome. Leukemia, 17, 68-75.
9. + progenitors cells or from monocytes differ in their ability to activate antigen-specific CD8+ cells. Journal of Immunology, 163, 3597-3604.
10. Ferrari, S., Rovati, B., Porta, C., Alessandrino, P.E., Bertolini, A., Collova, E., Riccardi, A. & Danova, M. (2003) Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard or high-dose chemotherapy plus granulocyte-colony stimulating factor. Cancer Immunology, Immunotherapy, 52, 359-366.
11. Fong, L. & Engleman, E.G. (2000) Dendritic cells in cancer immunotherapy. Annual Review of Immunology, 18, 245-273.
12. Fujii, S., Shimizu, K., Koji, F. & Kawano, F. (2003) Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential. Journal of Leukocyte Biology, 73, 82-90.
13. Galea-Lauri, J. (2002) Immunological weapons against acute myeloid leukaemia. Immunology, 107, 20-27.
14. Galea-Lauri, J., Darling, D., Mufti, G., Harrison, P. & Farzaneh, F. (2002) Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunology, Immunotherapy, 51, 299-310.
15. Gasparetto, C., Gasparetto, M., Morse, M., Rooney, B., Vredenburgh, J.J., Long, G.D., Rizzieri, D.A., Loftis, J., Chao, N.J. & Smith, C. (2002) Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3 ligand and G-CSF or GM-CSF. Cytokine, 18, 8-19.
16. Gazitt Y. (2000) Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors. Stem cells, 18, 390-398.
17. Guan, Y., Ralph, S. & Hogge, D.E. (2002) Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukaemia. Experimental Hematology, 30, 721-728.
18. Harrison, B.D., Adams, J.A., Briggs, M., Brereton, M.L. & Liu Yin, J.A. (2001) Stimulation of autologous proliferative and cytotoxic T-cell responses by 'leukemic dendritic cells' derived from blast cells in acute myeloid leukemia. Blood, 97, 2764-2771.
19. Herrera, C., Garcia-Perez, M.J., Ramirez, R., Martin, C., Alvarez, M.A., Martinez, F., Gomez, P., Garcia-Castellano, J.M. & Torres, A. (1997) Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony stimulating factor. Bone Marrow Transplantation, 19, 545-551.
20. Ho, C.S.K., Munster, D., Pyke, C.M., Hart, D.N.J. & López, A. (2002) Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood, 99, 2897-2904.
21. Hock, B.D., Haring, L.F., Ebbett, A.M., Patton, W.N. & McKenzie, J.L. (2002) Differential effects of G-CSF mobilization on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation. Bone Marrow Transplantation, 30, 733-740.
22. Keating, S., Suciu, S., de Witte, T., Zittoun, R., Mandelli, F., Belhabri, A., Amadori, S., Fibbe, W., Gallo, E., Fillet, G., Varet, B., Meloni, G., Hagemeijer, A., Fazi, P., Solbu, G. & Willemze, R. on behalf of the EORTC and GIMEMA leukemia groups. (2003) The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GiMEMA AML-10 trial. Leukemia, 17, 60-67.
23. Klangsinsirikul, P. & Russell, N.H. (2002) Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Experimental Hematology, 30, 495-501.
24. Löwenberg, B., Downing, J.R. & Burnett, A. (1999) Acute myeloid leukaemia. New England Journal of Medicine, 341, 1051-1062.
25. MacDonald, K.P.A., Munster, D.J., Clark, G.J., Dzionek, A., Schmitz, J. & Hart, D.N.J. (2002) Characterization of human blood dendritic cell subsets. Blood, 100, 4512-4520.
26. Martin, C., Torres, A., Leon, A., Rubio, V., Alvarez, M.A., Herrera, C., Jean-Paul, E., Correa, M.A., Rojas, R., Campos, R., Serrano, J., Romero, R., Roman, J., Guzman, J,L., Flores, R., Falcon, M., Martinez, F. & Gomez, P. (1998) Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome. Bone Marrow Transplantation, 21, 375-382.
27. Mohty, M., Jarrossay, D., Lafage-Pochitaloff, M., Zandotti, C., Brière, F., de Lamballeri, X.N., Isnardon, D., Sainty, D., Olive, D. & Gaugler, B. (2001) Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood, 98, 3750-3756.
28. Mohty, M., Olive, D. & Gaugler, B. (2002) Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts. Leukemia, 16, 2197-2204.
29. + dendritic cells and monocytes-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood, 100, 2858-2866.
30. +/33-fraction of AML with a more differentiated phenotype (CD33+). Leukemia, 9, 450-457.
31. Reiffers, J., Labopin, M., Sanz, M., Korbling, M., Blaise, D., De la Rubia, J. & Gorin N.C. (2000) Autologous blood cell vs marrow transplantation for acute myeloid leukaemia in complete remission: an EBMT retrospective analysis. Bone Marrow Transplantation, 25, 1115-1119.
32. Spisek, R., Chevallier, P., Morineau, N., Milpied, N., Avet-Loiseau, H., Harousseau, J.L., Meflah, K. & Gregorie, M. (2002) Induction of leukaemia-specific cytotoxic response by cross-presentation of late apoptotic leukemic blasts by autologous dendritic cells of non-leukemic origin. Cancer Research, 62, 2861-2868.
33. Tarella, C., Di Nicola, M., Caracciolo, D., Zallio, F., Cuttica, A., Omede, P., Bondesan, P., Magni, M., Matteucci, P., Gallamini, A., Pileri, A. & Gianni, A.M. (2002) High-dose Ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization. Bone Marrow Transplantation, 30, 725-732.
34. Thurner, B., Roder, C., Dieckmann, D., Heuer, M., Kruse, M., Glaser, A., Keikavoussi, P., Kampgen, E., Bender, A. & Schuler, G. (1999) Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. Journal of Immunological Methods, 223, 1-15.
35. Uchida, T., Ohashi, H., Aoki, E., Nakahara, Y., Hotta, T., Murate, T., Saito, H. & Kinoshita, T. (2000) Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP). Leukemia, 14, 207-212.
36. Vellenga, E., van Putten, W.L., Boogaerts, M.A., Daenen, S.M., Verhoef, G.E., Hagenbeek, A., Jonkhoff, A.R., Huijigens, P.C., Verdonck, L.F., van der Lelie, J., Schouten, H.C., Gmur, J., Wijermans, P., Gratwohl, A., Hess, U., Fey, M.F. & Lowenberg, B. (1999) Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia. Bone Marrow Transplantation, 12, 1279-1282.
37. hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101, 2314-2317.